Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Doog.....don't get me started on those LOL....you know how I feel. The FDA held up the ANDA's and still are. Its pathetic. However, Management needs to take responsibility here for staying on top of those issues and taking proper steps to minimize. If these generics are no longer viable, then they need to abandon them.

Keppra and Glucho sit idle and approved. we paid big bonuses on them as they get a bonus of the first 5 approvals. Yet, shareholders got nothing! Bonuses should be paid based on commercialization not approval.

If these ANDA's are now over glutted like Glucho is such a small profit per pill and Keppra is so small its not worth it. then they should have known that and abandoned them. we still have 3 more pending NOT partnered. I would hate to see a bonus paid for gaining an approval and then they shelf them.

Just telling it as it is LOL. I give compliments when they are do and complain when they screw up. I think its only fair. hopefully they learn from this and make necessary changes. thats how we all grow and learn from mistakes.

On the bright side, It does give us hope that so far Odidi is 100% on his drugs. he has obtained an approval on everything he has submitted so far. (even if still waiting on some) so it does show he can get it done, so Im focusing more on Rexista. but that is not an excuse to forget about the ANDA's and doing the right thing.